Panlin Capital Closes Chengdu Fund
Panlin Capital, a Shangai, China-based venture capital firm focusing on Chinese technological innovation, closed its 12th RMB-denominated main fund. Chengdu Panlin Xiangxu Fund is the first established...
View ArticleAtantares Closes Two RMB100 Million Financing Rounds
Atantares, a Beijing, China-based developer of develop molecular chips, closed a Pre-A and Pre-A+ financing all around RMB100m. The Pre-A round was led by Asia Green Fund, followed by Fosun Health...
View ArticleUnisun Energy Group Completes Series C Financing
Unisun Energy Group, a Shanghai, China-based provider of industrial and commercial intelligent green power services, raised an undisclosed amount in Series C funding. The round was led by Cathay...
View ArticleNeurophth Raises Nearly USD95M in Series C+ Financing
Neurophth Therapeutics, a Wuhan, China-based gene therapy company for ophthalmic diseases, raised nearly USD95M in Series C+ funding. The round was led by Yangtze River-CMB International Industry Fund,...
View ArticleEpigenic Therapeutics Raises $32M in Series A Funding
Epigenic Therapeutics, a Shanghai, China-based biotechnology company dedicated to developing gene modulation therapy to treat prevalent diseases, raised $32M in Series A funding. The round was co-led...
View ArticleInnovac Therapeutics Closes $18M Series Pre-A Financing
Innovac Therapeutics, a Boston, MA-, Shanghai and Hangzhou, China-based mRNA therapeutics company, raised $18M in Series Pre-A funding. The round saw participation from Elikon Venture, Vision Plus...
View ArticleGrit Biotechnology Closes $60M Series B Financing
Grit Biotechnology, a Shanghai, China-based cell therapy company, raised $60M in Series B funding. The round was led by CICC with participation from Qianhai Ark, Liando Group, Yuanhe Capital,...
View ArticleBlueRun Ventures China Rebrands to Lanchi Ventures
BlueRun Ventures China, a Beijing, China-based early-stage technology-focused venture firm, is changing its English brand to Lanchi Ventures. The firm has launched a new website www.lanchiventures.com...
View ArticleCanton Biologics Completes Over 300M Yuan Series C Financing
Canton Biologics, a Guangzhou, China-based molecule biopharmaceutical CDMO, raised over 300M Yuan in Series C funding. The round was led by SDIC Venture Capital, with participation from Guangdong...
View ArticleLynk Pharmaceuticals Completes Series C2 Financing
Lynk Pharmaceuticals, a Hangzhou, China-based clinical stage company, raised an undisclosed amount in Series C2 funding. The round saw participation from Shaoxing Binhai New Area Biomedical Industry...
View ArticleHydrexia Closes Series D Private Equity Financing
Hydrexia Holding Limited, a Shanghai, China-based integrated hydrogen technology solution provider, completed its Series D of private equity financing. The amount of the deal was not disclosed. The...
View ArticlePrins AI Raises $100M in Series B Funding
Prins AI, a technology company utilizing advanced AI to create digital identities for enterprises, brands, celebrities, and individuals, closed a $100m Series B financing round. The round was...
View ArticleSuperOrdinary Closes $58M Series B Funding
SuperOrdinary, a Shanghai, New York City, and Los Angeles-based global brand accelerator and expert in establishing and scaling brands in international and domestic channels, closed a $58M Series B...
View ArticleTriastek Closes USD 20.4M Pre-C Funding Round
Triastek, a Nanjing, China-based company which specializes in 3D printing for pharmaceutical industry, raised USD 20.4M in Pre-C funding. The round was led by Guoxin Investment, with participation from...
View ArticleOrbiMed Raises $4.3 Billion Across Three Private Investment Funds
OrbiMed, a global healthcare investment firm, raised more than $4.3 billion in commitments for its latest private investment funds. Investors in these new funds include a broad range of medical...
View ArticleTrax Receives $50M Financing
Trax, a Boston, MA-based provider of image recognition solutions for brick-and-mortar retail, raised $50M in financing. Deutsche Bank Private Credit & Infrastructure provided the financing. The...
View ArticleBoxPlus Information Technology Company Receives Investment From IQAX
BoxPlus Information Technology Company, a Shanghai, China-based provider of Internet of Things (IoT) solutions, received an investment from IQAX. The amount of the deal was not disclosed. The company...
View ArticleTSUN Raises Over RMB 150M in Series B Funding
TSUN, a Suzhou, China-based photovoltaic (PV) manufacturing company, raised over RMB 150M in Series B funding. The round was led by IDG Capital. The company intends to use the funds to enhance its...
View ArticleViva Biotech Secures Approx. US$ 210M Funding
Viva Biotech (01873.HK), a Hong Kong-based provider of services ranging from early-stage structure-based drug R&D to commercial drug delivery, raised approx US$210M in funding. The round saw...
View ArticleEacon Mining Technology Raises $55.22M in Funding
Eacon Mining Technology, a Beijing, China-based provider of autonomous haulage solutions (AHS), raised $55.22M in funding. The round, which brought the total amount to $62.13M, was led by Richen...
View ArticlePerpetual Medicines Raises $8M in Seed Funding
Perpetual Medicine, a Shanghai, China- and Boston, MA-based computational peptide therapeutics company, raised $8M in Seed funding. The round was led by Chengwei Capital. The company intends to use the...
View ArticleAdcentrx Extends Series A+ Financing to $51M
Adcentrx Therapeutics, a San Diego, CA- and Shanghai, China-based biotechnology company dedicated to developing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other life-threatening...
View ArticlePivotal Life Sciences Closes Pivotal bioVenture Partners Fund II, at $389M
Pivotal Life Sciences, a global investment firm dedicated to investing in companies involved in healthcare innovation seeking to improve patient outcomes, closed Pivotal bioVenture Partners Fund II, at...
View ArticleHi!Papa Closes Series A+ Fundraise
Hi!Papa, a Guangzhou, China-based personal care company focused on 3- to 12-year-old children in China, raised an undisclosed amount in Series A+ fundraise. The round was led by L Catterton. The...
View ArticleJJC TEC Completes Series E Financing
JJC TEC, a Beijing, China-based provider of high-end intelligent equipment for the oil and gas industry, completed an E-round financing. The round was led by SDIC Fund and Seekers Capital, followed by...
View ArticleFull-Life Technologies Raises USD $47.3M in Series B Funding
Full-Life Technologies, a Shanghai, China-based radiotherapeutics company, raised USD $63.3M in funding. The round, which included $47.3M in Series B equity financing and $16M in loan facilities, saw...
View ArticleAvistone Biotechnology Closes Series B Funding
Avistone Biotechnology, a Beijing, China-based biotechnology company focused on precision oncology therapeutics, closed a Series B financing of ~$140 million USD. The round was led by SDIC CS Capital...
View ArticleDocuments Receives Investment From Ushopal
Documents, a Chinese fragrance brand, received an investment from Ushopal. The amount of the deal was not disclosed. The company intends to use the investment to expand its international exposure and...
View ArticleNoahArk Tech Group Secures $2.4M Investment from EOS Network Ventures
NoahArk Tech Group, a Hong Kong-based company which operates in the decentralized finance (DeFi) sector, received a $2.4M investment from EOS Network. Noahark.io is a DeFi project on the EOS EVM chain,...
View ArticleHaomo Raises Over RMB 100M in Series B1 Funding
Haomo, a Beijing, China-based provider of a driver assistance system, raised over RMB 100M in Series B1 funding. Chengdu Wufa Private Equity Fund Management made the investment. The company intends to...
View Article
